These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15980055)

  • 1. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Morelli A; Pruzanski M; Pellicciari R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):58-68. PubMed ID: 15980055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.
    Fiorucci S; Antonelli E; Rizzo G; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pellicciari R; Morelli A
    Gastroenterology; 2004 Nov; 127(5):1497-512. PubMed ID: 15521018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pruzanski M; Morelli A; Pellicciari R
    J Pharmacol Exp Ther; 2005 Aug; 314(2):584-95. PubMed ID: 15860571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts.
    Renga B; Mencarelli A; Migliorati M; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
    Inflamm Res; 2011 Jun; 60(6):577-87. PubMed ID: 21279417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors and hepatic stellate cell activation.
    Miyahara T; Schrum L; Rippe R; Xiong S; Yee HF; Motomura K; Anania FA; Willson TM; Tsukamoto H
    J Biol Chem; 2000 Nov; 275(46):35715-22. PubMed ID: 10969082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
    Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
    J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.
    Galli A; Crabb DW; Ceni E; Salzano R; Mello T; Svegliati-Baroni G; Ridolfi F; Trozzi L; Surrenti C; Casini A
    Gastroenterology; 2002 Jun; 122(7):1924-40. PubMed ID: 12055599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
    Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
    J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
    Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
    Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.
    Da Silva Morais A; Abarca-Quinones J; Horsmans Y; Stärkel P; Leclercq IA
    Int J Mol Med; 2007 Jan; 19(1):105-12. PubMed ID: 17143554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.
    Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B
    J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
    Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S
    Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.
    Pellicciari R; Fiorucci S; Camaioni E; Clerici C; Costantino G; Maloney PR; Morelli A; Parks DJ; Willson TM
    J Med Chem; 2002 Aug; 45(17):3569-72. PubMed ID: 12166927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Zhi SC; Chen SZ; Li YY; Li JJ; Zheng YH; Yu FX
    Dig Dis Sci; 2019 Jun; 64(6):1560-1570. PubMed ID: 30673982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrotic effect of total flavonoids of Astmgali Radix on dimethylnitrosamine-induced liver cirrhosis in rats.
    Cheng Y; Mai JY; Wang MF; Chen GF; Ping J
    Chin J Integr Med; 2017 Jan; 23(1):48-54. PubMed ID: 27787720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the PPARγ agonist, GW570, in liver fibrosis.
    Yang L; Stimpson SA; Chen L; Wallace Harrington W; Rockey DC
    Inflamm Res; 2010 Dec; 59(12):1061-71. PubMed ID: 20585829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
    Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.